Effects of the extracorporeal membrane oxygenation circuit on plasma levels of ceftolozane.
ceftolozane/tazobactam
extracorporeal membrane oxygenation
pharmacokinetics
Journal
Perfusion
ISSN: 1477-111X
Titre abrégé: Perfusion
Pays: England
ID NLM: 8700166
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
pubmed:
8
8
2019
medline:
3
2
2021
entrez:
8
8
2019
Statut:
ppublish
Résumé
New antibiotics with bactericidal activity against multi-drug-resistant bacteria are increasingly used in the intensive care units. Here, we aimed to evaluate the influence of the extracorporeal membrane oxygenation on plasma levels of ceftolozane. A 34-year-old female was admitted to the intensive care unit after bilateral lung transplantation, complicated by primary graft dysfunction and cardiogenic shock needing venoarterial extracorporeal membrane oxygenation. Ceftolozane/tazobactam was started. Plasma ceftolozane levels were monitored on the first and third days of antibiotic treatment. A non-compartment pharmacokinetic analysis was performed and the extraction rate through the oxygenator was calculated. The extracorporeal circuit of extracorporeal membrane oxygenation may alter the pharmacokinetics of antibiotics, to varying degrees due to drug sequestration and increased distribution volume. In this case, the extracorporeal membrane oxygenation circuit had little impact on the ceftolozane plasma concentration. Plasma levels of ceftolozane are stable in the extracorporeal membrane oxygenation circuit, suggesting that adjustment of standard doses of ceftolozane in patients with extracorporeal membrane oxygenation support may not be needed.
Identifiants
pubmed: 31387460
doi: 10.1177/0267659119864813
doi:
Substances chimiques
Anti-Bacterial Agents
0
Cephalosporins
0
ceftolozane
37A4IES95Q
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM